$ORMP News Article - Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China
https://marketwirenews.com/news-releases/oram...22544.html